JP2018532113A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532113A5
JP2018532113A5 JP2018517367A JP2018517367A JP2018532113A5 JP 2018532113 A5 JP2018532113 A5 JP 2018532113A5 JP 2018517367 A JP2018517367 A JP 2018517367A JP 2018517367 A JP2018517367 A JP 2018517367A JP 2018532113 A5 JP2018532113 A5 JP 2018532113A5
Authority
JP
Japan
Prior art keywords
pathogen
biological sample
adsorption medium
mannose
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018517367A
Other languages
English (en)
Japanese (ja)
Other versions
JP6898923B2 (ja
JP2018532113A (ja
Filing date
Publication date
Priority claimed from US14/885,729 external-priority patent/US10487350B2/en
Application filed filed Critical
Publication of JP2018532113A publication Critical patent/JP2018532113A/ja
Publication of JP2018532113A5 publication Critical patent/JP2018532113A5/ja
Application granted granted Critical
Publication of JP6898923B2 publication Critical patent/JP6898923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018517367A 2013-11-08 2016-10-14 吸着媒体を使用する感染症の診断方法 Active JP6898923B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361902070P 2013-11-08 2013-11-08
US14/885,729 2015-10-16
US14/885,729 US10487350B2 (en) 2013-11-08 2015-10-16 Methods for diagnosing infectious diseases using adsorption media
PCT/US2016/057121 WO2017066627A1 (en) 2013-11-08 2016-10-14 Methods for diagnosing infectious diseases using adsorption media

Publications (3)

Publication Number Publication Date
JP2018532113A JP2018532113A (ja) 2018-11-01
JP2018532113A5 true JP2018532113A5 (https=) 2019-11-21
JP6898923B2 JP6898923B2 (ja) 2021-07-07

Family

ID=53042095

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016528141A Active JP6806563B2 (ja) 2013-11-08 2014-11-06 吸着媒体を使用する感染症の診断法
JP2018517367A Active JP6898923B2 (ja) 2013-11-08 2016-10-14 吸着媒体を使用する感染症の診断方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016528141A Active JP6806563B2 (ja) 2013-11-08 2014-11-06 吸着媒体を使用する感染症の診断法

Country Status (10)

Country Link
US (3) US10487350B2 (https=)
EP (2) EP3065796B1 (https=)
JP (2) JP6806563B2 (https=)
CN (2) CN105705177B (https=)
AU (2) AU2014346668C1 (https=)
BR (1) BR112016009827B1 (https=)
CA (2) CA2928866C (https=)
ES (1) ES2799398T3 (https=)
MX (2) MX382486B (https=)
WO (3) WO2015069942A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1960016T3 (en) 2005-12-13 2017-01-09 Exthera Medical Corp Method for extracorporeal removal by a pathogenic MI-KROBE, an inflammatory cell or inflammatory protein from the blood.
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
EP2509604B1 (en) 2009-12-01 2021-03-17 ExThera Medical Corporation Device for removing cytokines from blood with surface immobilized polysaccharides
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
MX376935B (es) 2013-06-24 2025-03-07 Exthera Medical Corp Sistema de filtración de sangre que contiene substrato recubierto con manosa.
CA2928866C (en) * 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
AU2015250107A1 (en) 2014-04-24 2016-11-17 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
EP3735281B1 (en) 2018-01-05 2024-11-27 Path Ex, Inc. Device for the capture and removal of disease material from fluids
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
US20220233756A1 (en) * 2019-05-17 2022-07-28 George A. Herzlinger Methods and systems for treating microbial disease
US20240093313A1 (en) * 2019-07-23 2024-03-21 Snapdna System and method for detecting and monitoring pathogens
FR3102773B1 (fr) * 2019-10-31 2024-04-05 Microbs Sas Dispositif contenant des billes de verre fonctionnalisées, et leur utilisation pour capter les micro-organismes
JP2023001488A (ja) * 2021-06-21 2023-01-06 三菱重工業株式会社 核酸抽出方法

Family Cites Families (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3782382A (en) 1972-02-03 1974-01-01 K N Enterprises Inc Means for blood administration and the like
US4103685A (en) 1976-01-05 1978-08-01 Lupien Paul J Method and apparatus for extravascular treatment of blood
JPS54127493U (https=) 1978-02-25 1979-09-05
JPS6040926B2 (ja) 1979-07-24 1985-09-13 三菱重工業株式会社 マンドレルバ−の自動サポ−ト装置
US4430496A (en) 1980-01-17 1984-02-07 Varian Associates, Inc. Strong anion exchange composition and methods
US4415665A (en) 1980-12-12 1983-11-15 Pharmacia Fine Chemicals Ab Method of covalently binding biologically active organic substances to polymeric substances
JPS5853757A (ja) 1981-09-25 1983-03-30 Denki Kagaku Kogyo Kk 免疫アフイニテイクロマトグラフイ−用吸着体及びその製法
SE8200751L (sv) 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
JPS58146354A (ja) 1982-02-26 1983-08-31 日機装株式会社 体液浄化器の製造法
US4820302A (en) 1982-04-22 1989-04-11 Sterling Drug Inc. Bio compatible and blood compatible materials and methods
CA1221307A (en) 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
GB2141554A (en) 1983-06-15 1984-12-19 Philips Electronic Associated A slit imaging system using two concave mirrors
DE3609021A1 (de) 1985-03-25 1986-09-25 Bio-Rad Laboratories, Inc., Richmond, Calif. Chromatographisches trennmedium fuer die schnelle analyse von kleinen proben
DE3519011A1 (de) 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
CA1327963C (en) 1987-09-08 1994-03-22 Ryuichi Yokohari Autoantibody adsorbent and apparatus for removing autoantibodies using the same
DE3880647T2 (de) 1987-11-20 1993-11-18 Kanegafuchi Chemical Ind Sorbentmittel für Serum-Amyloid-Proteine.
US4955870A (en) * 1988-08-23 1990-09-11 Ridderheim Kristen A Hypodermic syringe with retractable needle
AU6441490A (en) 1989-09-18 1991-04-18 Cuno Incorporated Filter media and use for pyrogen removal
JPH0489500A (ja) 1990-07-31 1992-03-23 Kirin Brewery Co Ltd アフィニティクロマトグラフィーによる物質の精製法および精製装置
SE469256B (sv) 1991-02-18 1993-06-14 Medscand Ab Rengoeringsprodukt
WO1992017502A1 (en) 1991-03-26 1992-10-15 Otsuka Pharmaceutical Factory, Inc. Adsorbed cellular fibronectin and process for separating and purifying fibronectins
US5211850A (en) 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood
DE4217917A1 (de) 1992-05-30 1993-12-02 Job Prof Dr Med Harenberg Immobilisation von chemisch kovalent gebundenem Heparin an Polymere mit Arylresten im Polymer
DE4331358A1 (de) 1992-10-12 1994-04-14 Braun Melsungen Ag Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten
US5344455A (en) 1992-10-30 1994-09-06 Medtronic, Inc. Graft polymer articles having bioactive surfaces
US5437861A (en) 1993-03-16 1995-08-01 Applied Immune Sciences, Inc. Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome
JP2643823B2 (ja) 1993-03-25 1997-08-20 有限会社 エンゼル総合研究所 吸着材料及びその製造方法
NO931809L (no) 1993-05-19 1994-11-21 Norsk Hydro As Hemofilter
US5447859A (en) 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
WO1995005400A1 (en) 1993-08-19 1995-02-23 Minnesota Mining And Manufacturing Company Heparin functional affinity supports
JPH07178161A (ja) 1993-12-24 1995-07-18 Terumo Corp 医療器具
JP3901216B2 (ja) 1995-02-16 2007-04-04 株式会社カネカ 腫瘍壊死因子−αの吸着剤、吸着除去方法および前記吸着剤を用いた吸着器
SE9501056D0 (sv) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
US6312907B1 (en) 1995-04-24 2001-11-06 The Texas A & M University System DbpA compositions and methods of use
AU6267796A (en) 1995-06-07 1996-12-30 Cerus Corporation Methods and devices for the removal of psoralens from blood products
US6544727B1 (en) 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
WO1997000969A1 (de) 1995-06-20 1997-01-09 Johannes Schumacher Verfahren und vorrichtung zur bestimmung der aktivität von enzymen in flüssigkeiten, beziehungsweise der konzentration und/oder aktivität von inhibitoren in flüssigkeiten
WO1997018844A1 (en) * 1995-11-21 1997-05-29 Pall Corporation Inactivation method and system in biological fluids
EP0796865B1 (en) 1996-03-18 2003-06-04 Kaneka Corporation Adsorbent and method for removing chemokines of the CC subtype from body fluids
RU2089283C1 (ru) 1996-03-23 1997-09-10 Научно-исследовательская фирма "Ультрасан" Био-, гемосовместимые сорбенты на основе сверхсшитых полимеров стирола с модифицированной поверхностью, способ их получения (варианты) и способ получения матрицы сорбента
SE507028C2 (sv) 1996-08-06 1998-03-16 Medicarb Ab Ny medicinsk användning
AU5811498A (en) * 1996-12-31 1998-07-31 Robert L. Stephon Microsphere-enhanced immunoassay for the detection of veterinary diseases
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
TW514537B (en) 1997-03-25 2002-12-21 Kanegafuchi Chemical Ind Adsorbent for removing hepatitis c virus and adsorption apparatus
DE69832066T2 (de) 1997-05-27 2006-07-13 Sanofi-Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporalen kreisläufen
US6465170B2 (en) * 1997-06-13 2002-10-15 Baxter Aktiengesellschaft Method for depleting viral and molecular pathogens in a biological material
US6197568B1 (en) 1997-07-29 2001-03-06 The Regents Of The University Of Michigan Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms
US20020159995A1 (en) 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US20020197249A1 (en) 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
US20020197250A1 (en) 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US6053894A (en) * 1997-08-04 2000-04-25 Shadd, Jr.; Daniel L. Hypodermic syringe
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US6136424A (en) 1998-02-06 2000-10-24 Renal Tech International, Llc Method of and material for purification of physiological liquids of organism, and method of producing the material
GB9804632D0 (en) 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
US8197430B1 (en) 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6248127B1 (en) 1998-08-21 2001-06-19 Medtronic Ave, Inc. Thromboresistant coated medical device
JP2000086688A (ja) 1998-09-04 2000-03-28 Ngk Insulators Ltd パルボウイルス吸着糖鎖リガンドおよびこれを利用したパルボウイルス除去装置
NO984143L (no) 1998-09-09 2000-03-10 Norsk Hydro As Ny prosess for å fremstille overflatemodifiserende stoffer
AU5670299A (en) * 1998-10-19 2000-05-08 Cbd Technologies Ltd. Methods of concentrating microorganisms using affinity separation
WO2000037172A1 (en) 1998-12-22 2000-06-29 Toray Industries, Inc. Materials for removing bacterial components
WO2000038763A1 (en) 1998-12-24 2000-07-06 Toray Industries, Inc. Method for purifying blood and column for purifying blood
US6297272B1 (en) 1999-01-12 2001-10-02 Hauser, Inc. Artemisinin analogs having antimalarial antiproliferative and antitumor activities and chemoselective methods of making the same
JP2000217575A (ja) 1999-02-01 2000-08-08 Masashi Funayama 生理活性物質、ヒト血球分化細胞およびヒト細胞の吸着体。
IN191696B (https=) 1999-02-12 2003-12-20 Council Scient Ind Res
DE19916352A1 (de) 1999-04-12 2000-10-19 Braun Melsungen Ag Entfernung von hüllehaltigen Viren aus Blut, Plasma oder Serum
WO2000066260A1 (en) 1999-04-28 2000-11-09 Toray Industries, Inc. Materials for eliminating cannabinoids and columns for the elimination of cannabinoids with the use of the same
WO2001018060A1 (fr) 1999-09-08 2001-03-15 Toray Industries, Inc. Materiaux de circulation extracorporelle, adsorbants de facteurs de complication diabetique, reservoirs servant a eliminer des facteurs de complication diabetique et procede d'elimination de facteurs de complication diabetique
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
JP2001178817A (ja) 1999-12-24 2001-07-03 Terumo Corp 人工腎臓用装置およびこれを用いた品質評価装置ならびに流体回路
US7067060B2 (en) 2000-01-11 2006-06-27 Nephros, Inc. Ionic enhanced dialysis/diafiltration system
JP2001190273A (ja) * 2000-01-14 2001-07-17 Jsr Corp ウイルス濃縮用粒子、該粒子を使用するウイルス濃縮方法およびウイルス検出方法
GB0001450D0 (en) * 2000-01-21 2000-03-08 Genpoint As Cell isolation method
WO2001067105A1 (en) 2000-03-06 2001-09-13 Dade Behring Marburg Gmbh Carriers coated with polysaccharides, their preparation and use
WO2001074420A1 (en) 2000-04-05 2001-10-11 Toray Industries, Inc. Adsorbents for high mobility group proteins and column for purifying body fluid
US7181261B2 (en) 2000-05-15 2007-02-20 Silver James H Implantable, retrievable, thrombus minimizing sensors
DE10045434B4 (de) 2000-09-14 2005-07-14 Fresenius Hemocare Gmbh Adsorbens mit unterschiedlich modifizierten Oberflächenbereichen, Verfahren zu dessen Herstellung und Verwendung davon
JP4283430B2 (ja) 2000-09-26 2009-06-24 株式会社カネカ エンテロトキシンの吸着材、吸着除去方法および吸着器
US8178304B2 (en) 2000-10-06 2012-05-15 Smith Terry J Diagnostic methods relating to Graves' disease and other autoimmune disorders
US8153121B2 (en) 2000-10-06 2012-04-10 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
US6509104B2 (en) 2000-12-05 2003-01-21 Michigan Biotechnology Institute Antithrombogenic polymer coating
JP2004516896A (ja) 2000-12-29 2004-06-10 アップフロント・クロマトグラフィー・アー/エス 細胞外体液からの特異的生体高分子物質の体外捕獲
JP4138488B2 (ja) 2001-01-30 2008-08-27 株式会社カネカ 直接血液灌流が可能な体液処理器
DE10117043A1 (de) 2001-04-05 2002-11-07 Gerhard Puetz Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
US20020197252A1 (en) 2001-04-10 2002-12-26 Renal Tech International Selective adsorption devices and systems
US6773412B2 (en) 2001-04-13 2004-08-10 Chf Solutions, Inc. User interface for blood treatment device
WO2002090990A1 (fr) * 2001-05-09 2002-11-14 Kyowa Medex Co., Ltd. Gel renfermant un biopolymere
JP2003128502A (ja) 2001-10-18 2003-05-08 Noritake Co Ltd 有害物質の処理材およびその製造方法
CA2463422A1 (en) 2001-10-10 2003-04-24 Noritake Co., Limited Photocatalytic material selectively inactivating biologically harmful substance and utilization thereof
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US20030148017A1 (en) 2001-12-07 2003-08-07 Olli Tuominen Copolymer coating for a hydrophobic membrane
US6951846B2 (en) 2002-03-07 2005-10-04 The United States Of America As Represented By The Secretary Of The Army Artemisinins with improved stability and bioavailability for therapeutic drug development and application
JP2005519744A (ja) 2002-03-14 2005-07-07 バクスター・インターナショナル・インコーポレイテッド 化合物除去器
WO2003090781A1 (en) 2002-04-23 2003-11-06 Meir Strahilevitz Methods and devices for targeting a site in a mammal and for removing species from a mammal
JP2005523336A (ja) * 2002-04-24 2005-08-04 ザ カウンシル オブ ザ クイーンズランド インスティテュート オブ メディカル リサーチ マンノース結合レクチン及びその使用方法
EP1521624A2 (en) 2002-07-11 2005-04-13 Upfront Chromatography A/S An extracorporeal stabilised expanded bed adsorption method for the treatment of sepsis
DE60326864D1 (de) * 2002-07-24 2009-05-07 Bio Rad Laboratories Proteininteraktionsdifferenzabbildung
US7207964B2 (en) 2003-03-17 2007-04-24 Hemavation, Llc Apparatus and method for down-regulating immune system mediators in blood
US20040182783A1 (en) 2003-03-17 2004-09-23 Walker Kimberly A. Filter and concentrator device for treatment of blood
PT2103694E (pt) * 2003-08-15 2011-07-26 Univ South Florida Materiais e métodos para a captura de patogénios e a remoção de ácido aurintricarboxílico de uma amostra
CN1255106C (zh) 2003-09-26 2006-05-10 李国桥 复方青蒿素
US7399400B2 (en) 2003-09-30 2008-07-15 Nano-Proprietary, Inc. Nanobiosensor and carbon nanotube thin film transistors
WO2005051313A2 (en) 2003-11-19 2005-06-09 Chiron Corporation Methods and reagents for treating, preventing and diagnosing bunyavirus infection
CN1988926B (zh) 2004-07-23 2010-05-05 株式会社钟化 填充有除去了水不溶性微粒的吸附材料的直接血液灌注用吸附器、与除去了水不溶性微粒的直接血液灌注用吸附材料的取得方法
JP2008508952A (ja) 2004-08-04 2008-03-27 アスピラ バイオシステムズ, インコーポレイテッド 部分的分子インプリントを用いる体液からの生体分子の捕獲および除去
US7850858B2 (en) 2004-08-30 2010-12-14 Kaneka Corporation Granulocyte adsorbent
CN1300587C (zh) * 2004-12-20 2007-02-14 山东省医药生物技术研究中心 检测血液脑脊液病原体抗体的蛋白芯片及其制备方法与应用
US8445293B2 (en) * 2005-02-09 2013-05-21 Rapid Pathogen Screening, Inc. Method to increase specificity and/or accuracy of lateral flow immunoassays
FR2884715B1 (fr) 2005-04-20 2007-06-15 Sanofi Aventis Sa Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
GB0509433D0 (en) 2005-05-09 2005-06-15 Uni For Milj Og Biovitenskap Method
EP2508867A1 (en) 2005-06-24 2012-10-10 Board Of Regents, The University Of Texas System Systems and methods including self-contained cartridges with detection systems and fluid delivery systems
WO2008045021A2 (en) 2005-08-01 2008-04-17 Rensselaer Polytechnic Institute Blood compatible nanomaterials and methods of making and using the same
US7776911B2 (en) 2005-11-07 2010-08-17 Indian Institute Of Science Antimalarial drug containing synergistic combination of curcumin and artemisinin
WO2007058592A1 (en) 2005-11-21 2007-05-24 Ge Healthcare Bio-Sciences Ab A method of chromatography using semi-synthetic heparin ligands
DK1960016T3 (en) 2005-12-13 2017-01-09 Exthera Medical Corp Method for extracorporeal removal by a pathogenic MI-KROBE, an inflammatory cell or inflammatory protein from the blood.
CN103235147B (zh) * 2005-12-21 2015-08-12 梅索斯卡莱科技公司 分析装置的液体分配器
US8211048B2 (en) 2006-02-22 2012-07-03 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
WO2007146162A2 (en) 2006-06-08 2007-12-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Devices, systems and methods for reducing the concentration of a chemical entity in fluids
US20090173685A1 (en) 2006-06-16 2009-07-09 Terumo Kabushiki Kaisha Blood treatment filter and blood treatment circuit
FR2902670B1 (fr) 2006-06-22 2009-04-24 Gambro Lundia Ab Utilisation d'une suspension pour traiter un support a usage medical, support a usage medical, echangeur et dispositif d'adsorption comprenant le support
WO2008147382A1 (en) 2006-09-27 2008-12-04 Micronics, Inc. Integrated microfluidic assay devices and methods
MX2009004460A (es) 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding
WO2008128251A1 (en) 2007-04-17 2008-10-23 The Children's Hospital Of Philadelphia Humanized viral vectors and methods of use thereof
CA2684457A1 (en) 2007-04-19 2008-10-30 C.G.M.3 Ltd Device system and method for monitoring and controlling blood analyte levels
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
AU2008265838A1 (en) 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
JP4226050B1 (ja) 2007-09-12 2009-02-18 株式会社Reiメディカル 体液浄化処理用吸着カラム
EP2224883A1 (en) 2007-11-16 2010-09-08 Smith & Nephew, Inc. Annular ring implant
CN101952727A (zh) * 2007-12-31 2011-01-19 3M创新有限公司 微生物捕获用组合物和方法
US11051733B2 (en) 2008-01-18 2021-07-06 Wake Forest University Health Sciences Isolating and purifying cells for therapy
FR2926993B1 (fr) 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
EP2087916A1 (en) 2008-02-11 2009-08-12 ICinnovation BV Electrosorption device for the purification of blood and other fluids
US9067017B2 (en) 2008-06-23 2015-06-30 Temasek Polytechnic Flow system of a dialysis device and a portable dialysis device
US20100021622A1 (en) * 2008-07-24 2010-01-28 National Chiao Tung University Apparatus and method for forming multilayer polymer thin film
US20100040546A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
EA023912B1 (ru) 2008-09-10 2016-07-29 АйТиЭйч ИММЬЮН ТЕРАПИ ХОЛДИНГЗ АБ Лечение воспалительных состояний
US8310415B2 (en) 2008-09-30 2012-11-13 Animas Corporation Medical devices using bistable displays
US8430831B2 (en) 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US20140256761A1 (en) 2009-04-22 2014-09-11 Robert Lewis Steele Enhanced artemisinin-based combination therapy for treating parasitic mediated disease
US20140011830A1 (en) 2012-07-06 2014-01-09 Robert Lewis Steele Artemisinin-Based Combination Therapy For Treating Parasitic Mediated Disease
US20130071474A1 (en) 2009-04-22 2013-03-21 James Spencer COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES
US20130072513A1 (en) 2009-04-22 2013-03-21 James Spencer COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES
US8801922B2 (en) 2009-06-24 2014-08-12 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Dialysis system
JP2012532886A (ja) 2009-07-10 2012-12-20 エボルバ アクチェンゲゼルシャフト ジイン組成物
EP2509604B1 (en) 2009-12-01 2021-03-17 ExThera Medical Corporation Device for removing cytokines from blood with surface immobilized polysaccharides
US8481757B2 (en) 2010-02-04 2013-07-09 Georgua Tech Research Corporation Compounds and compositions useful in the treatment of malaria
AU2011215942B8 (en) 2010-02-09 2014-02-13 Exthera Medical Corporation Removal of virulence factors through extracorporeal therapy
WO2011133287A1 (en) 2010-04-19 2011-10-27 The Trustees Of Columbia University In The City Of New York Portable blood filtration devices, systems, and methods
US20130288370A1 (en) 2010-10-15 2013-10-31 Cytopherx, Inc. Cytopheresis cartridges and use thereof
WO2012099721A2 (en) * 2011-01-18 2012-07-26 The Regents Of The University Of California Real-time adaptive immune system and method
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US20130131423A1 (en) 2011-04-12 2013-05-23 Tianxin Wang Methods to detect and treat diseases
ES2800316T3 (es) 2011-06-13 2020-12-29 Tla Targeted Immunotherapies Ab Tratamiento del cáncer
WO2013012924A2 (en) * 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2556849A1 (en) 2011-08-08 2013-02-13 Gambro Lundia AB Separation material
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
US20140011829A1 (en) 2012-07-06 2014-01-09 Robert Lewis Steele Artemisinin-Based Combination Therapy For Treating Viral Mediated Disease
WO2014085713A1 (en) 2012-11-30 2014-06-05 The Methodist Hospital Research Institute Methods and compositions for detecting tuberculosis
MX376935B (es) 2013-06-24 2025-03-07 Exthera Medical Corp Sistema de filtración de sangre que contiene substrato recubierto con manosa.
JP2016531874A (ja) 2013-09-26 2016-10-13 ファーマケア,インク. オートタキシン阻害剤化合物
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
AU2015250107A1 (en) 2014-04-24 2016-11-17 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
DE202016001950U1 (de) 2016-03-30 2017-07-03 Leybold Gmbh Vakuumpumpe
IL275968B2 (en) 2018-01-10 2024-07-01 Xwpharma Ltd Prodrugs of ketamine, compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2018532113A5 (https=)
JP2017513636A5 (https=)
Warnes et al. Human coronavirus 229E remains infectious on common touch surface materials
Tseng et al. A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography
WO2009079571A3 (en) Methods for detecting defects in inorganic-coated polymer surfaces
JP2008245635A5 (https=)
WO2006033662A3 (en) Methods and kits for detection of multiple pathogens
JP6920423B2 (ja) 光学積層体ならびにこれを有する画像表示装置の前面板、画像表示装置、抵抗膜式タッチパネルおよび静電容量式タッチパネル
JP2007523325A5 (https=)
JP2013505007A5 (https=)
JP2017500014A5 (https=)
EP2178897A4 (en) NUCLEIC ACID SEQUENCES FOR AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES
FR2881755B1 (fr) Milieux pour la detection specifique de micro-organismes resistants
DE602006010946D1 (de) Ampholytisches Polymer und seine Verwendung
WO2010014820A3 (en) Particles for use in supported nucleic acid ligation and detection sequencing
BRPI0718277A2 (pt) Método para a imobilização de um polissacarídeo em um veículo, veículo, coleção de microesfera ou contas, biossensor, sistema de detecção de ressonância de plasmon de superfície, e, métodos para a determinação da presença de um anticorpo direcionado a um antígeno de uma bactéria gram-negativa em uma amostra, e para a determinação da presença de uma bactéria gram-negativa em uma amostra.
Prata et al. Ultracentrifugation as a direct method to concentrate viruses in environmental waters: virus-like particle enumeration as a new approach to determine the efficiency of recovery
JP7540667B2 (ja) アデノウイルス精製の方法
WO2016077294A1 (en) Methods and kits for post-ivt rna purification
Shi et al. Elution is a critical step for recovering human adenovirus 40 from tap water and surface water by cross-flow ultrafiltration
JP2009515556A5 (https=)
Greaves et al. Particle association and size fraction of molecular viral fecal pollution indicators in wastewater
JP2013517768A (ja) 急速な病原体検出技術および装置
McMinn Optimization of adenovirus 40 and 41 recovery from tap water using small disk filters
Schultz et al. Collaborative validation of a rapid method for efficient virus concentration in bottled water